PYPL vs REGN · P/E 7.9, rev $33.17B vs P/E 14, rev $14.34B
PayPal Holdings Inc (PYPL) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
PayPal Holdings Inc (PYPL) is a credit services company listed on NASDAQ. It is led by Alex Chriss.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported PYPL revenue for 2025-12-31 was $33.17B. Net income was $5.23B. Revenue was up 4.3% from 2024-12-31 to 2025-12-31. PYPL currently screens at market cap $37.12B and trailing P/E 7.9.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
PYPL currently screens at market cap $37.12B and trailing P/E 7.9. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the PYPL and REGN stock pages for the full models.
Not investment advice.